The Autonomous University of Barcelona also known as UAB is a public university mostly located in Cerdanyola del Vallès, near the city of Barcelona in Catalonia, Spain.As of 2012, it consists of 57 departments in the experimental, life, social and human science, spread among 13 faculties/schools. All these centers together award a total of 85 qualifications in the form of first degrees, diplomas, and engineering degrees. Moreover, almost 80 doctoral programs, and more than 80 other postgraduate programs are offered. UAB has more than 40,000 students and more than 3,600 academic and research staff. The UAB is a pioneering institution in terms of fostering research. There are many research institutes in the campus, as well as other research centers, technical support services and service-providing laboratories. Vila Universitària is the residential complex of the Universitat Autònoma de Barcelona, located on its campus, which has 812 apartments with a total housing capacity for 2193 persons and very good train and bus connections, only 25 minutes away from the centre of Barcelona.The UAB is considered to be the best University in Spain by the 2012 QS World University Rankings, which ranked the university 176th overall in the world. Its subject rankings were: 144th in Life science & Biomedicine, 92th in Arts & Humanities, 106th in Natural science, 95th in Social science and 203rd in Engineering & IT. Wikipedia.

The present invention relates to a compound of general formula I and to the use thereof as a hapten.
An object of the present invention is also a conjugate of said compound I with a carrier protein or fragment thereof, with a detectable labelling agent, or with a polymer or support, and to the use thereof for producing antibodies. Furthermore, the present invention also relates to a method for the detection and/or quantification of 1-hydroxyphenazine and/or pyocyanin using said antibodies and conjugates for the detection of infections caused by

The present invention relates to the use of inclusion bodies as vehicles for therapeutic protein delivery. This method is applicable to the delivery of therapeutic proteins to intracellular locations. In addition, the invention also relates to the administration of a cell or a pharmaceutical composition comprising inclusion bodies formed by therapeutic proteins. These inclusion bodies formed by therapeutic proteins could be used for the treatment of different diseases.